Cryoablation Combined With Sintilimab Plus Lenvatinib in 1L Treatment of Advanced ICC (CASTLE-ICC-Chemo-free)

Clinical trial NCT05835245 · UNKNOWN

Trial details

NCT number: NCT05835245
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Intrahepatic Cholangiocarcinoma

Start date: 2023-04-28
Primary completion: 2025-12-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.